Abiopharma

News list

Malzahn Craig 🔴 sold 1.2K shares of REGENXBIO Inc. (RGNX) at $14.40 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Full text

News bot Jan. 6, 2026, 10:41 p.m.
🔍 Malzahn Craig (Executive)

Company: REGENXBIO Inc. (RGNX)

Report Date: 2026-01-02
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 1,238
Detailed Transactions and Holdings:
- Sold 1,238 shares of Common Stock at $14.4 per share (Direct)
  Date: 2026-01-02 | Code: F | equity_swap_involved: false | shares_owned_after: 16,347.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 3, 2022, January 3, 2023, and January 2, 2024. The number of shares withheld was determined on January 2, 2026 based on the closing price of the issuer's common stock on December 31, 2025.